ArticleBMC public health2019
Impact of removing cost sharing under the affordable care act (ACA) on mammography and pap test use.
Article in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Decomposition of medical imaging spending growth between 2010 and 2021 in the US employer-insured population.Health affairs scholar · 2024Article
- Retrenchment of Wisconsin's Well Woman Program and changes in insurance coverage around the Affordable Care Act.Preventive medicine reports · 2022Article
- Obamacare: A bibliometric perspective.Frontiers in public health · 2022Article
- Utilization and cost sharing for preventive cancer screenings.Health policy OPEN · 2021Article
- Change in mammography screening attendance after removing the out-of-pocket fee: a population-based study in Sweden (2014-2018).Cancer causes & control : CCC · 2021Article
- A framework for personalized mammogram screening.Preventive medicine reports · 2021Article
- Perceived Financial Barriers to Cervical Cancer Screening and Associated Cost Burden Among Low-Income, Under-Screened Women.Journal of women's health (2002) · 2021Article
- Use of cervical cancer preventive services among US women aged 21-29: an assessment of the 2010 Affordable Care Act rollout through 2018.Cancer causes & control : CCC · 2020Article
- Trends in Unmet Need for Physician and Preventive Services in the United States, 1998-2017.JAMA internal medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Affordable Care Act (ACA) required private insurers and Medicare to cover recommended preventive services without any cost sharing to improve utilization of these services. This study is an attempt to identify the impact of removing cost sharing on mammography and pap test utilization rates.
methodsCounterfactual analysis was used to predict what would have been the screening rates in post-ACA if ACA was not there. This was done by estimating a model that examines determinants of dependent variable for the pre-ACA year (pre-ACA year is 2009). The estimated model was then used to predict the dependent variable for the post-ACA year using individual characteristics and other relevant variables unlikely to be affected by ACA (post-ACA year is 2016). Effect of ACA is defined as the difference between the values of dependent variables in post-ACA and the predicted values of dependent variables in the post-ACA year using counterfactual.
resultsThe counterfactual analysis show that the utilization of mammogram and pap test did not improve following ACA.
conclusionRemoval of cost-sharing under the ACA did not improve mammography or pap test rates. Therefore, financial barrier may not be an important factor in affecting utilization of the screening tests and policy makers should focus on other non-financial barriers in order to improve coverage of the tests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.